all subjects enrolled were identified as high risk for ponv, administered general anesthesia and a prophylactic antiemetic of 4 mg of iv ondansetron, and randomized to receive ipa or promethazine for treatment of breakthrough ponv demographics, verbal numeric rating scale (vnrs) scores for nausea, time to 50% reduction in vnrs scores, and overall antiemetic and incidence of ponv were measured.